PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity

Noonan syndrome (NS) is a developmental disorder characterized by facial dysmorphia, short stature, cardiac defects, and skeletal malformations. We recently demonstrated that mutations in PTPN11, the gene encoding the non-receptor-type protein tyrosine phosphatase SHP-2 (src homology region 2-domain phosphatase-2), cause NS, accounting for approximately 50% of cases of this genetically heterogeneous disorder in a small cohort. All mutations were missense changes and clustered at the interacting portions of the amino-terminal src-homology 2 (N-SH2) and protein tyrosine phosphatase (PTP) domains. A gain of function was postulated as a mechanism for the disease. Here, we report the spectrum and distribution of PTPN11 mutations in a large, well-characterized cohort with NS. Mutations were found in 54 of 119 (45%) unrelated individuals with sporadic or familial NS. There was a significantly higher prevalence of mutations among familial cases than among sporadic ones. All defects were missense, and several were recurrent. The vast majority of mutations altered amino acid residues located in or around the interacting surfaces of the N-SH2 and PTP domains, but defects also affected residues in the C-SH2 domain, as well as in the peptide linking the N-SH2 and C-SH2 domains. Genotype-phenotype analysis revealed that pulmonic stenosis was more prevalent among the group of subjects with NS who had PTPN11 mutations than it was in the group without them (70.6% vs. 46.2%; P<.01), whereas hypertrophic cardiomyopathy was less prevalent among those with PTPN11 mutations (5.9% vs. 26.2%; P<.005). The prevalence of other congenital heart malformations, short stature, pectus deformity, cryptorchidism, and developmental delay did not differ between the two groups. A PTPN11 mutation was identified in a family inheriting Noonan-like/multiple giant-cell lesion syndrome, extending the phenotypic range of disease associated with this gene.     

Conditional Over-Expression of Estrogen Receptor Alpha in a Transgenic Mouse Model

Attempts to delineate the mechanisms of estrogen action have promoted the creation of several estrogen receptor alpha (ER) mouse models in the past decade. These traditional models are limited by the fact that the receptors are either absent or present throughout all stages of development. The purpose of this work was to develop a conditional transgenic model that would provide an in vivo method of controlling the spatial and temporal regulation of ER expression. The tetracycline responsive system was utilized. Three lines of transgenic mice carrying a transgene composed of the coding sequence for murine ER placed under the regulatory control of a tet operator promoter (tet-op) were generated. These three lines of tet-op-mER mice were each mated to an established line of transgenic mice expressing a tetracycline-dependent transactivator protein (tTA) from the mouse mammary tumor virus-long terminal repeat (MMTV-LTR). Double transgenic MMTV-tTA/tet-op-mER mice were produced. All three lines demonstrated dominant gain of ER shown by RT-PCR, immunoprecipitation, and immunohistochemistry. Transgene-specific ER was expressed in numerous tissues including the mammary gland, salivary gland, testis, seminal vesicle, and epididymis. Expression was silenced by administration of doxycycline in the drinking water. This model can be utilized to evaluate the consequences of ER dominant gain in targeted tissues at specific times during development. In this study dominant gain of ER was associated with a reduction in epididymal/vas deferens and seminal vesicle weights consistent with the proposed action of ER on fluid transport in the male reproductive tract. Combining this model with other dominant gain and gene knockout mouse models will be useful for testing effects of ER action in combination with specific gene products and to evaluate if developmental and stage-specific expression of ER can rescue identified phenotypes in gene knockout mice.     

The role of chloride in O2 evolution by thylakoids from salt-tolerant higher plants

(1) Thylakoids isolated from leaves of two salt-tolerant higher plant species were found to require high (greater than 250 mM) concentrations of Cl⁻ for maximal rates of photosynthetic O₂ evolution and maximum variable chlorophyll a fluorescence yield. These activities were also tolerant to extremely high (2–3 M) salt concentrations. Their pH dependence was markedly different in the absence and presence of sufficient salt levels. (2) When Cl⁻ was provided as CaCl₂, as opposed to MgCl₂, KCl or NaCl, higher rates of O₂ evolution were obtained, suggesting that Ca²⁺ has an important role in Photosystem II reactions. (3) The site of Cl⁻ action was located on the electron donor side of Photosystem II. (4) O₂ evolution in the presence of optimal Cl⁻ concentrations showed a pH dependence closely matched by that of ³⁵Cl-NMR line broadening, which is indicative of Cl⁻ binding. This pH-dependent ³⁵Cl-NMR line-width broadening was not altered significantly by treatment of the thylakoids with EDTA; it was, however, abolished by heat treatment. (5) Only anions with similar ionic radii (Br⁻, NO⁻₃) were effective in replacing Cl⁻. Small anions such as F⁻ and OH⁻ were inhibitory; larger ions had no effect. The inhibition by F⁻ is due, at least in part, to displacement of Cl⁻. The selectivity is attributed to a combination of steric and ionic field effects. (6) It is proposed that Cl⁻ facilitates Photosystem II electron transport by reversible ionic binding to the O₂-evolving complex itself or to the thylakoid membrane in close proximity to it.     

Testicular development in an SRY-negative 46,XX individual harboring a distal Xp deletion

A case of a true hermaphrodite presenting with a karyotype of 46,X,del(X)(p21.1pter) is described. The testis-determining gene, SRY, was not detected in DNA prepared from either peripheral blood lymphocytes or from a gonad biopsy. The patient also presented with a series of discrete somatic abnormalities, including abnormal skin and retinal pigmentation, and mental retardation. The extent of the Xp deletion was mapped by Southern blotting. X chromosome replication studies of lymphoblast cells prepared from the patient indicated that the deleted X chromosome was inactivated in all cells examined. It is suggested that the phenotype of the patient is caused by the unmasking of a recessive allele(s) on the grossly intact X chromosome. The relationship between the Xp deletion, the intersex phenotype, and the possible role of an Xp locus involved in human sex determination is discussed.     

Expression of <Emphasis Type="Italic">MAX2</Emphasis> under <Emphasis Type="Italic">SCARECROW</Emphasis> promoter enhances the strigolactone/MAX2 dependent response of <Emphasis Type="Italic">Arabidopsis</Emphasis> roots to low-phosphate conditions

Main conclusion

MAX2/strigolactone signaling in the endodermis and/or quiescent center of the root is partiallysufficient to exert changes in F-actin density and cellular trafficking in the root epidermis, and alter gene expression during plant response to low Pi conditions.Strigolactones (SLs) are a new group of plant hormones that regulate different developmental processes in the plant via MAX2, an F-box protein that interacts with their receptor. SLs and MAX2 are necessary for the marked increase in root-hair (RH) density in seedlings under conditions of phosphate (Pi) deprivation. This marked elevation was associated with an active reduction in actin-filament density and endosomal movement in root epidermal cells. Also, expression of MAX2 under the SCARECROW (SCR) promoter was sufficient to confer SL sensitivity in roots, suggesting that SL signaling pathways act through a root-specific, yet non-cell-autonomous regulatory mode of action. Here we show evidence for a non-cell autonomous signaling of SL/MAX2, originating from the root endodermis, and necessary for seedling response to conditions of Pi deprivation. SCR-derived expression of MAX2 in max2-1 mutant background promoted the root low Pi response, whereas supplementation of the synthetic SL GR24 to these SCR:MAX2 expressing lines further enhanced this response. Moreover, the SCR:MAX2 expression led to changes in actin density and endosome movement in epidermal cells and in TIR1 and PHO2 gene expression. These results demonstrate that MAX2 signaling in the endodermis and/or quiescent center is partially sufficient to exert changes in F-actin density and cellular trafficking in the epidermis, and alter gene expression under low Pi conditions.

     

Development of erythropoiesis in the mouse

Hematopoiesis consists of a small number of stem cells which rise to a progeny of several distinct lineages. Among these, cells of the erythroid lineage emerge early in the mammalian embryo and provide indispensable functions throughout gestation and postnatal life. Knowledge of the existence of two distinct erythroid lineages, traditionally known as primitive and definitive, has more than a century. In the last decade, it has become evident that the ontogeny of erythropoiesis is more complex than a simple two-steps model. This review summarizes the development and differentiation of the erythroid lineage cells during gestation, and also the characteristics of erythropoiesis during the infant stage, discussing which issues remain open and which need further research.     

Expedient synthesis of N-Z-pyroglutamyl-amino acid derivatives

N-Z-pyroglutamyl pseudopeptides 3a-c are shown to be conveniently prepared from glutamyl-bis-Bt 1a by cyclization of an N-terminal glutamic acid residue. Structures are supported by 2D NMR studies and by comparison with the same products prepared by direct coupling of the C-terminus activated N-pGlu 1b and free amino acids 2a-c.     

Multifunctional Manganese Ions Trapping and Hydrofluoric Acid Scavenging Separator for Lithium Ion Batteries Based on Poly(ethylene‐alternate‐maleic acid) Dilithium Salt

Manganese dissolution from positive electrodes seriously reduces the life of Li‐ion batteries, due to its detrimental impact on the passivation of negative electrodes. A novel multifunctional separator incorporating inexpensive mass‐produced polymeric materials may dramatically increases the durability of Li‐ion batteries. The separator is made by embedding the poly(ethylene‐alternate‐maleic acid) dilithium salt polymer into a poly(vinylidene fluoride‐hexafluoropropylene) copolymer matrix. LiMn₂O₄‐graphite cells comprising a 1 m LiPF₆ solution in ethylene carbonate plus dimethyl carbonate (1:1 v/v) and the functional separator retain 31% and 100% more capacity than baseline cells with plain commercial separators after 100 cycles at C/5 rate, respectively, at 30 and 55 °C. Analyses of cycled cells indicate greatly reduced Mn contamination of the graphite negative electrodes and almost no irreversible structural change in the LiMn₂O₄ positive electrodes from cells containing the functional separator. The Mn amount in the graphite electrodes from cycled cells with functional separators is ≈80% lower than in the graphite electrodes from cycled baseline cells. Mn ions are found in the functional separators but not in baseline (plain) separators from cycled cells. Finally, it is shown that the reported performance improvements stem from the ability of the novel separator to chelate Mn ions and to scavenge trace HF.